Aurinia Pharmaceuticals Analyst Ratings
BenzingaMar 1 14:07 ET
Aurinia Pharmaceuticals: Strong Buy Rating Amidst Share Repurchase and Promising LUPKYNIS Prospects
TipRanksMar 1 11:55 ET
Aurinia Pharmaceuticals Analyst Ratings
BenzingaFeb 23 12:09 ET
Aurinia Pharmaceuticals Analyst Ratings
BenzingaFeb 22 06:42 ET
Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN) and Aurinia Pharmaceuticals (AUPH)
TipRanksFeb 22 06:30 ET
Aurinia Pharmaceuticals: A Buy Rating on Strong Lupkynis Sales and Streamlined Operations
TipRanksFeb 18 23:47 ET
Aurinia Pharmaceuticals Analyst Ratings
BenzingaFeb 16 11:11 ET
Aurinia Stock Downgraded by Bloom Burton Amid Strategic Challenges
InvestingFeb 16 08:42 ET
Analysts Are Bullish on These Healthcare Stocks: Valneva (VALN), Aurinia Pharmaceuticals (AUPH)
TipRanksFeb 15 12:20 ET
Aurinia Pharmaceuticals (AUPH) Gets a Buy From RBC Capital
TipRanksFeb 14 07:16 ET
H.C. Wainwright Sticks to Its Buy Rating for Aurinia Pharmaceuticals (AUPH)
TipRanksJan 8 06:27 ET
Strong Sales Performance and Market Outperformance: A Buy Rating for Aurinia Pharmaceuticals
TipRanksNov 6, 2023 01:12 ET
Strong 3Q Performance and Growing Lupkynis Sales Bolster Aurinia Pharmaceuticals' Buy Rating: An In-depth Analysis by David Martin, PhD
TipRanksNov 5, 2023 13:05 ET
RBC Capital Sticks to Their Buy Rating for Aurinia Pharmaceuticals (AUPH)
TipRanksNov 3, 2023 09:47 ET
Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), Aurinia Pharmaceuticals (AUPH) and Cerevel Therapeutics Holdings (CERE)
TipRanksNov 2, 2023 14:00 ET
Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Aurinia Pharmaceuticals (AUPH) and Aquestive Therapeutics (AQST)
TipRanksSep 22, 2023 06:21 ET
HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $15 Price Target
BenzingaSep 22, 2023 06:20 ET
Aurinia Pharmaceuticals Analyst Ratings
BenzingaSep 22, 2023 06:18 ET
HC Wainwright & Co. Maintains Buy on Aurinia Pharmaceuticals, Raises Price Target to $15
BenzingaAug 7, 2023 12:02 ET
Aurinia Pharmaceuticals Analyst Ratings
BenzingaAug 7, 2023 12:01 ET
No Data
No Data